Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: Effect on ciliary beat frequency

International Journal of Pharmaceutics

Volumn 263, Issue 1-2, 2003, Pages 95-103

  Dimova, S ^a,b   Mugabowindekwe, R ^c   Willems, T ^d   Brewster, M E ^b   Noppe, M ^b   Ludwig, A ^c   Jorissen, M ^d   Augustijns, P ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

3 Methoxyquercetin; Ciliary beat frequency; Human nasal epithelial cells

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 3 METHOXYQUERCETIN; 5,7,3',4' TETRAHYDROXY 3 O METHYLFLAVONE; ANTIVIRUS AGENT; POLYSORBATE 80; QUERCETIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CILIARY MOTILITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; DRUG SOLUBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; NOSE MUCOSA; NOSE POLYP; PHOTOMETRY; PRIORITY JOURNAL;

EID: 0042884320     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00363-6     Document Type: Article

References (45)

1. Agu R.U., Jorissen M., Willems T., Van den Mooter G., Kinget R., Augustijns P. Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: a comparative study of cell culture models. Pharm. Res. 16:1999;1380-1385.
2. Agu R.U., Jorissen M., Willems T., Van den Mooter G., Kinget R., Verbeke N., Augustijns P. Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis. Int. J. Pharm. 193:2000;219-226.
3. Agu R.U., Jorissen M., Willems T., Augustijns P., Kinget R., Verbeke N. In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies. J. Pharm. Pharmacol. 53:2001;1447-1456.
4. Agu R.U., Jorissen M., Kinget R., Verbeke N., Augustijns P. Alternatives to in vivo nasal toxicological screening for nasally-administered drugs. S.T.P. Pharm. Sci. 12:2002;13-22.
5. Andersen I., Proctor D.F. Measurement of nasal mucociliary clearance. Eur. J. Respir. Dis. Suppl. 127:1983;37-40.
6. Asai K., Morishita M., Katsuta H., Hosoda S., Shinomiya K., Noro M., Nagai T., Takayama K. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. Int. J. Pharm. 246:2002;25-35.
7. Batts A.H., Marriott C., Martin G.P., Wood C.F., Bond S.W. The effect of some preservatives used in nasal preparations on the mucus and ciliary components of mucociliary clearance. J. Pharm. Pharmacol. 42:1990;145-151.
8. Boers F., Deng B.L., Lemiere G., Lepoivre J., De Groot A., Dommisse R., Vlietinck A.J. An improved synthesis of the anti-picornavirus flavone 3-O-methylquercetin. Arch. Pharm. (Weinheim). 330:1997;313-316.
9. Chilvers M.A., McKean M., Rutman A., Myint B.S., Silverman M., O'Callaghan C. The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur. Respir. J. 18:2001;965-970.
10. Cornaire G., Woodley J.F., Saivin S., Legendre J.Y., Decourt S., Cloarec A., Houin G. Effect of polyoxyl 35 castor oil and polysorbate 80 on the intestinal absorption of digoxin in vitro. Arzneimittelforschung. 50:2000;576-579.
11. Cos P., Ying L., Calomme M., Hu J.P., Cimanga K., Van Poel B., Pieters L., Vlietinck A.J., Vanden Berghe D. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod. 61:1998;71-76.
12. De Meyer, N., 1989. Synthese en antiviraal onderzoek van niet-natuurlijke 3-methoxyflavonen. Ph.D. Thesis, University of Antwerp (UIA).
13. De Meyer N., Haemers A., Mishra L., Pandey H.K., Pieters L.A., Vanden Berghe D.A., Vlietinck A.J. 4′-Hydroxy-3-methoxyflavones with potent antipicornavirus activity. J. Med. Chem. 34:1991;736-746.
14. Delamanche S., Desforges P., Morio S., Fuche C., Calvet J.H. Effect of oleoresin capsicum (OC) and ortho-chlorobenzylidene malononitrile (CS) on ciliary beat frequency. Toxicology. 165:2001;79-85.
15. Deng, B.L., 1998. Synthesis of 3-methoxyflavones and their biological evaluation. Doctoral Thesis, University of Antwerp (RUCA).
16. Deng, B.-L., Lepoivre, J.A., Lemiere, G., Dommisse, R., Claeys, M., Boers, F., De Groot, A., 1997. A practical synthesis of 3-methoxyflavones. Liebigs Ann. Chem., 2169-2175.
17. Di Benedetto G., Manara-Shediac F.S., Mehta A. Effect of cyclic AMP on ciliary activity of human respiratory epithelium. Eur. Respir. J. 4:1991;789-795.
18. Ferrell J.E. Jr., Chang Sing P.D., Loew G., King R., Mansour J.M., Mansour T.E. Structure/activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices. Mol. Pharmacol. 16:1979;556-568.
19. Hermens W.A., Merkus F.W. The influence of drugs on nasal ciliary movement. Pharm. Res. 4:1987;445-449.
20. Hermens W.A., Hooymans P.M., Verhoef J.C., Merkus F.W. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro. Pharm. Res. 7:1990;144-146.
21. Joki S., Saano V., Nuutinen J., Virta N., Karttunen P., Silvasti M., Toskala E. Effects of some preservative agents on rat and guinea pig tracheal and human nasal ciliatry beat frequency. Am. J. Rhinol. 10:1996;181-186.
22. Jorissen M., Van der Schueren B., Tyberghein J., Van der Berghe H., Cassiman J.J. Ciliogenesis and coordinated ciliary beating in human nasal epithelial cells cultured in vitro. Acta Otorhinolaryngol. Belg. 43:1989;67-73.
23. Jorissen M., Willems T., De Boeck K. Diagnostic evaluation of mucociliary transport: from symptoms to coordinated ciliary activity after ciliogenesis in culture. Am. J. Rhinol. 14:2000;345-352.
24. 2+ and cAMP. Am. J. Physiol. 263:1992;L232-L242.
25. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85:1996;1017-1025.
26. Merkus F.W., Verhoef J.C., Romeijn S.G., Schipper N.G. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. 8:1991;588-592.
27. Merkus P., Romeijn S.G., Verhoef J.C., Merkus F.W., Schouwenburg P.F. Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope. 111:2001;595-602.
28. Middleton E. Jr., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52:2000;673-751.
29. Mucsi I., Pragai B.M. Inhibition of virus multiplication and alteration of cyclic AMP level in cell cultures by flavonoids. Experimentia. 41:1985;930-931.
30. Pelzer L.E., Guardia T., Osvaldo Juarez A., Guerreiro E. Acute and chronic antiinflammatory effects of plant flavonoids. Farmacology. 53:1998;421-424.
31. Rajewski R.A., Stella V.J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85:1996;1142-1169.
32. Rhee C.S., Min Y.G., Lee C.H., Kwon T.Y., Lee C.H., Yi W.J., Park K.S. Ciliary beat frequency in cultured human nasal epithelial cells. Ann. Otol. Rhinol. Laryngol. 110:2001;1011-1016.
33. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 178:1999;55-65.
34. Tirucherai G.S., Pezron I., Mitra A.K. Novel approaches to nasal delivery of peptides and proteins. S.T.P. Pharma. Sci. 12:2002;3-12.
35. Tsuchiya Y., Shimizu M., Hiyama Y., Itoh K., Hashimoto Y., Nakayama M., Horie T., Morita N. Antiviral activity of natural occurring flavonoids in vitro. Chem. Pharm. Bull. 33:1985;3881-3886.
36. Vanden Berghe, D.A.R., Haemers, A., Vlietinck, A.J., 1993. Antiviral agents from higher plants and an example of structure-activity relationship of 3-methoxyflavones. In: Colegate, S.M., Molyneux, R.J. (Eds.), Bioactive Natural Products: Detection, Isolation and Structural Determination. CRC Press, London, Chapter 17, pp. 405-440.
37. Van der Baan B. Ciliary function. Acta Otorhinolaryngol. Belg. 54:2000;293-298.
38. Van Hoof L., Vanden Berghe D.A., Hatfield G.M., Vlietinck A.J. Plant antiviral agents. V. 3-Methoxyflavones as potent inhibitors of viral-induced block of cell synthesis. Planta Med. 50:1984;513-517.
39. Van Zuylen L., Verweij J., Sparreboom A. Role of formulation vehicles in taxane pharmacology. Invest. New Drugs. 19:2001;125-141.
40. Vlietinck A.J., Vanden Berghe D.A., Van Hoof L.M., Vrijsen R., Boeye A. Antiviral activity of 3-methoxyflavones. Prog. Clin. Biol. Res. 213:1986;537-540.
41. Vrijsen R., Everaert L., Van Hoof L.M., Vlietinck A.J., Vanden Berghe D.A., Boeye A. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis. Antiviral Res. 7:1987;35-42.
42. Winther B. Effects on the nasal mucosa of upper respiratory viruses (common cold). Dan. Med. Bull. 41:1994;193-204.
43. Wyatt T.A., Spurzem J.R., May K., Sisson J.H. Regulation of ciliary beat frequency by both PKA and PKG in bovine airway epithelial cells. Am. J. Physiol. 275:1998;L827-L835.
44. Yoshitsugu M., Hanamure Y., Furuta S., Deguchi K., Ueno K., Rautiainen M. Ciliary motility and surface morphology of cultured human respiratory epithelial cells during ciliogenesis. Biol. Cell. 82:1994;211-216.
45. Zhou M., Donovan M.D. Recovery of the nasal mucosa following laureth-9 induced damage. Int. J. Pharm. 130:1996;93-102.